Neoplasms
Showing NaN - NaN of 73
Bladder Cancer, Urinary Bladder Tumor, Urologic Tumors Trial in Los Angeles, Boston (Fiducial marker placement, Multiparametric
Recruiting
- Bladder Cancer
- +4 more
- Fiducial marker placement
- Multiparametric MRI (mpMRI)
-
Los Angeles, California
- +1 more
Jan 7, 2022
Neuroblastoma, Neuroectodermal Tumors, Tumors Trial in United States (131I-MIBG, 131-MIBG + Vorinostat)
Recruiting
- Neuroblastoma
- +2 more
- 131I-MIBG
- 131-MIBG + Vorinostat
-
San Francisco, California
- +15 more
Jan 7, 2022
Tumors, NUT Carcinoma Trial in Worldwide (BI 894999)
Completed
- Neoplasms
- NUT Carcinoma
- BI 894999
-
Boston, Massachusetts
- +15 more
Dec 3, 2021
Tumors, Heart Failure, Kidney Diseases Trial in Boston, Hershey (Making Your Wishes Known, Standard advance care planning)
Completed
- Neoplasms
- +3 more
- Making Your Wishes Known
- Standard advance care planning
-
Boston, Massachusetts
- +1 more
Aug 12, 2021
Tumors, Arteriovenous Malformation of CNS, Trigeminal Neuralgia Trial in Australia, Turkey, United States (SRS/SBRT)
Recruiting
- Neoplasms
- +2 more
- SRS/SBRT
-
Colorado Springs, Colorado
- +24 more
Jul 19, 2021
Tumors Trial in United States (NY-ESO-1(c259)T Cells, Fludarabine, Cyclophosphamide)
Completed
- Neoplasms
- NY-ESO-1(c259)T Cells
- +2 more
-
Duarte, California
- +7 more
Jun 9, 2021
Tumors, Melanoma, Colorectal Tumor Trial in United States (ASN003 ascending doses, ASN003 MTD)
Terminated
- Neoplasms
- +3 more
- ASN003 ascending doses
- ASN003 MTD
-
Los Angeles, California
- +4 more
May 17, 2019
Tumors, Triple-Negative Breast Cancer Trial in United States (PF-06647263)
Terminated
- Neoplasms
- Triple-Negative Breast Cancer
-
Boston, Massachusetts
- +9 more
Jan 24, 2019
Tumors Trial in Spain, United Kingdom, United States (PF-05212384 (also known as PKI-587))
Completed
- Neoplasms
- PF-05212384 (also known as PKI-587)
-
Boston, Massachusetts
- +8 more
Mar 5, 2018
Tumors, Malignant Carcinoma Trial in Boston, Villejuif (Neratinib, Temsirolimus)
Completed
- Neoplasms
- Malignant Carcinoma
-
Boston, Massachusetts
- +4 more
Aug 17, 2018
Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of Varlilumab and Atezolizumab)
Terminated
- Carcinoma, Renal Cell
- +13 more
- Combination of Varlilumab and Atezolizumab
-
San Francisco, California
- +3 more
Apr 26, 2018
Views of Cancer Patients Regarding Financial Conflicts of
Completed
- Neoplasms
-
Denver, Colorado
- +4 more
Jun 30, 2017